Colonial Trust’s CASI Pharmaceuticals CASI Stock Holding History

Colonial Trust’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11	Closed	-$9	–	1141
2025 Q4	$9	Hold	11	–	–	﹤0.01%	1094
2025 Q3	$18	Hold	11	–	–	﹤0.01%	1087
2025 Q2	$13	Hold	11	–	–	﹤0.01%	1091
2025 Q1	$24	Hold	11	–	–	﹤0.01%	1092
2024 Q4	$31	Hold	11	–	–	﹤0.01%	1319
2024 Q3	$68	Hold	11	–	–	﹤0.01%	1102
2024 Q2	$61	Hold	11	–	–	﹤0.01%	979
2024 Q1	$40	Hold	11	–	–	﹤0.01%	981
2023 Q4	$79	Hold	11	–	–	﹤0.01%	956
2023 Q3	$28	Hold	11	–	–	﹤0.01%	945
2023 Q2	$28	Hold	11	–	–	﹤0.01%	937
2023 Q1	$26	Hold	11	–	–	﹤0.01%	895
2022 Q4	$20	Buy	+11	New	+$22	﹤0.01%	903

Other funds holding CASI

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Colonial Trust's CASI Position: Q1 2026 in Review

Colonial Trust sold out of CASI Pharmaceuticals (CASI) in Q1 2026, closing a stake of 11 shares — an estimated $9 sold.

Colonial Trust first reported a position in CASI in Q4 2022 and held it in 13 quarters. The position peaked at $79 in Q4 2023. 1 fund tracked by Wall St. Rank holds CASI as of Q1 2026.

Colonial Trust reported no remaining CASI Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Colonial Trust sold 11 CASI Pharmaceuticals shares in Q1 2026, an estimated $9.
Colonial Trust first reported a position in CASI Pharmaceuticals in Q4 2022 and held it in 13 quarters.
Colonial Trust's CASI Pharmaceuticals position peaked at $79 in Q4 2023.
1 fund tracked by Wall St. Rank held CASI Pharmaceuticals as of Q1 2026.

Based on Colonial Trust's 13F filing for Q1 2026, filed 12 May 2026.